Safety and Efficacy Study of Paricalcitol Versus Calcitriol in the Treatment of Secondary Hyperparathyroidism
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether oral paricalcitol is safer and more
efficacious compared to oral calcitriol in the treatment of hyperparathyroidism in chronic
kidney disease patients undergoing dialysis.